ChinaBio® Partnering Forum 2021 Hybrid

10 - 14 May 2021, Shanghai, China


Introduction
Accelerate your cross-border strategies and expand your reach into the vibrant China life science market. 

ChinaBio® Partnering Forum is the largest and most productive life science partnering event in China. To be held as a 5-day hybrid event; 2 days in-person, 3 days virtually, May 10–14, 2021, the conference will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for a week of successful partnering. 

ChinaBio® Partnering Forum 2020 Digital attracted 1,000+ delegates from over 500 companies and 27 countries, making it a must-attend global event for companies interested in developing cross-border partnerships, both inside and outside of China. The 2021 edition promises to be even better with the added ability to attend in-person and virtually, with top notch attendance from pharma and biotech companies and investors, as well as leading executives from China’s fast-growing life sciences hubs and researchers from China's top universities and institutes. 

The conference also features EBD Group’s gold-standard partnering platform, partneringONE®, enabling delegates to efficiently identify, meet and network with companies from across the life science value chain in a virtual format, with each meeting prescheduled with its own video conferencing link. 

In addition to partnering meetings, the event will feature a blend of live and on-demand program sessions, company presentations, table-top exhibits, company showcases, and networking sessions.  
Venue
Hybrid Event

Hybrid Event, Hybrid Event, Shanghai, 201204, China

Organised by
EBD Group, Inc. and ChinaBio® Group. EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*